Study supports new screening method for cervical cancer
Vari Drennan Professor, Healthcare and policy research at Kingston University and St George’s, University of London
A national roll-out of screening for routine primary high risk human papillomavirus (hrHPV) is under way in England. To support it, a large pilot study of routine testing for hrHPV examined the prevalence and incidence of cervical intraepithelial neoplasia (CIN, the pre-cancerous abnormalities) and cancer, comparing it with liquid-based cytology (LBC).
Primary Health Care.
29, 2, 13-13.
doi: 10.7748/phc.29.2.13.s11
Want to read more?
Already subscribed? Log in
OR
Unlock full access to RCNi Plus today
Save over 50% on your first 3 months
Your subscription package includes:
- Unlimited online access to all 10 RCNi Journals and their archives
- Customisable dashboard featuring 200+ topics
- RCNi Learning featuring 180+ RCN accredited learning modules
- RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests
Subscribe
Alternatively, you can purchase access to this article for the next seven days. Buy now
Or